Question 1

What is the catalog number for Hsa-miR-556-5p mimic?

Accepted Answer

The catalog number for Hsa-miR-556-5p mimic is HY-R01720.

Question 2

What sizes are available for Hsa-miR-556-5p mimic?

Accepted Answer

Hsa-miR-556-5p mimic is available in the following size(s): 5 nmol, 20 nmol.

Question 3

How many pack sizes does Hsa-miR-556-5p mimic come in?

Accepted Answer

Hsa-miR-556-5p mimic is available in 2 different pack sizes.

Question 4

Is Hsa-miR-556-5p mimic in stock?

Accepted Answer

Hsa-miR-556-5p mimic is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

Who manufactures Hsa-miR-556-5p mimic?

Accepted Answer

Hsa-miR-556-5p mimic is manufactured by QuantiMol.

Question 6

What is the estimated delivery time for Hsa-miR-556-5p mimic?

Accepted Answer

Estimated delivery time for Hsa-miR-556-5p mimic is approximately 15 business day(s), depending on your location.

Question 7

Where can I find the safety data sheet (SDS/MSDS) for Hsa-miR-556-5p mimic?

Accepted Answer

The safety data sheet for Hsa-miR-556-5p mimic is available here: http://file.medchemexpress.com/batch_PDF/HY-R01720/hsa-miR-556-5p-mimic-SDS-MedChemExpress.pdf.

Question 8

What is Hsa-miR-556-5p mimic used for?

Accepted Answer

Hsa-miR-556-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

Hsa-miR-556-5p mimic

Product Specifications

UNSPSC

Target

Type

Related Pathways

Applications

Field of Research

Assay Protocol

Purity

Solubility

Smiles

Molecular Weight

Shipping Conditions

Storage Conditions

Scientific Category

Clinical Information

Available Sizes

Frequently Asked Questions

Explore Other Products

AFAP1 protein (His tag)

Goat Polyclonal Goat anti-Rabbit IgG (H+L) Secondary Antibody [PE/Atto594]

AGN 205327

Ctdsp1 Rat shRNA Plasmid (Locus ID 363249)

Anti-Human CD309 Recombinant Antibody (Ramucirumab)

Anti-Human CD309 Recombinant Antibody (Ramucirumab)